SCHEMBL4039684

SCHEMBL4039684

CCC(c1ccccc1)c1cccnc1CN(Cc1ncc(C)cc1C)C1CCNCC1

nearest known ligand 0.40

Predicted protein targets (top 10)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 5/20 0.40
SLC6A2 P23975 15/20 0.38
SLC6A4 P31645 15/20 0.38
SLC6A3 Q01959 7/20 0.37
CHRM2 P08172 1/20 0.35
CHRM4 P08173 1/20 0.35
CHRM5 P08912 1/20 0.35
CYP2D6 P10635 1/20 0.35
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2082182 0.87 SLC6A2 (0.43) CXCR4SLC6A2SLC6A4SLC6A3CHRM2
SCHEMBL4030777 0.87 SLC6A2 (0.43) CXCR4SLC6A2SLC6A4SLC6A3CHRM2
SCHEMBL4030779 0.85 SLC6A2 (0.42) CXCR4SLC6A2SLC6A4SLC6A3
SCHEMBL4030780 0.83 SLC6A2 (0.42) CXCR4SLC6A2SLC6A4SLC6A3
SCHEMBL2082385 0.82 CXCR4 (0.42) CXCR4SLC6A2SLC6A4SLC6A3CHRM2
SCHEMBL2084715 0.79 CXCR4 (0.40) CXCR4SLC6A2SLC6A4SLC6A3CHRM2
SCHEMBL2083962 0.78 SLC6A2 (0.40) CXCR4SLC6A2SLC6A4SLC6A3
SCHEMBL4035549 0.77 SLC6A2 (0.42) CXCR4SLC6A2SLC6A4SLC6A3CHRM2
SCHEMBL4032057 0.77 SLC6A2 (0.41) SLC6A2SLC6A4SLC6A3CYP2D6
SCHEMBL2081862 0.77 SLC6A2 (0.39) CXCR4SLC6A2SLC6A4SLC6A3CHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1613613-A4 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC (CA) 2009-03-25 EP disclosed
EP-1613613-A2 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC. (CA) 2006-01-11 EP disclosed
WO-2004091518-A2 CXCR4 CHEMOKINE RECEPTOR BINDING COMPOUNDS ANORMED INC. (CA) 2004-10-28 WO disclosed